BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Keskar V, Sood MM. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con. Clin J Am Soc Nephrol 2016;11:2085-92. [PMID: 27797891 DOI: 10.2215/CJN.03200316] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Sy J, Hsiung JT, Edgett D, Kalantar-Zadeh K, Streja E, Lau WL. Cardiovascular and Bleeding Outcomes with Anticoagulants across Kidney Disease Stages: Analysis of a National US Cohort. Am J Nephrol 2021;52:199-208. [PMID: 33789276 DOI: 10.1159/000514753] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Bansal N. Use of Oral Anticoagulation for Patients with ESRD on Hemodialysis with Atrial Fibrillation: Verdict 1. Clin J Am Soc Nephrol 2016;11:2093-4. [PMID: 27797899 DOI: 10.2215/CJN.08610816] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
3 Rigatto C. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 3. Clin J Am Soc Nephrol 2016;11:2097. [PMID: 27797901 DOI: 10.2215/CJN.09230816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Reinecke H, Jürgensmeyer S, Engelbertz C, Gerss J, Kirchhof P, Breithardt G, Bauersachs R, Wanner C. Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study. BMJ Open 2018;8:e022690. [PMID: 30206088 DOI: 10.1136/bmjopen-2018-022690] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
5 Mace-Brickman T, Eddeen AB, Carrero JJ, Mark PB, Molnar AO, Lam NN, Zimmerman D, Harel Z, Sood MM. The Risk of Stroke and Stroke Type in Patients With Atrial Fibrillation and Chronic Kidney Disease. Can J Kidney Health Dis 2019;6:2054358119892372. [PMID: 31839975 DOI: 10.1177/2054358119892372] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Airy M, Chang TI, Ding VY, Goldstein BA, Bansal N, Niu J, Navaneethan SD, Turakhia MP, Winkelmayer WC. Risk profiles for acute health events after incident atrial fibrillation in patients with end-stage renal disease on hemodialysis. Nephrol Dial Transplant 2018;33:1590-7. [PMID: 29145634 DOI: 10.1093/ndt/gfx301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
7 Alfano G, Fontana F, Iannaccone M, Noussan P, Cappelli G. Preoperative management of arteriovenous fistula (AVF) for hemodialysis. J Vasc Access 2017;18:451-63. [PMID: 29027182 DOI: 10.5301/jva.5000771] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Herzog CA. Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2. Clin J Am Soc Nephrol 2016;11:2095-6. [PMID: 27797902 DOI: 10.2215/CJN.09470916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
9 Werfel S, Lorenz G, Haller B, Günthner R, Matschkal J, Braunisch MC, Schaller C, Gundel P, Kemmner S, Hayek SS, Nusshag C, Reiser J, Moog P, Heemann U, Schmaderer C. Application of regularized regression to identify novel predictors of mortality in a cohort of hemodialysis patients. Sci Rep 2021;11:9287. [PMID: 33927289 DOI: 10.1038/s41598-021-88655-0] [Reference Citation Analysis]